Latest Industry Insights
Diagnostic Biomarkers in Human Primary Membranous Nephropathy: anti-PLA2R, anti-THSD7A and Beyond
In this article, we discuss the role of anti-PLA2R and anti-THSD7A antibodies in the diagnosis of primary membranous nephropathy and highlight why there is a need to measure these biomarkers before kidney transplants.
The Antibody Test That Quantifies COVID-19 Vaccine Protection
Dr Stephen Russell explores how measuring neutralizing antibody levels can help understand how risk levels can change over time and determine optimal vaccine dosing strategies.
Collaboration Between Organizations Is the Key to Getting Ahead of the COVID-19 Pandemic
Testing for the presence of the SARS-CoV-2 virus continues to be critical across the world, and will be in the future, particularly in light of new variants. The key to expanding and perfecting testing lies, arguably, in effective partnerships between organizations.
Trends, Applications and Advances in Spatial Transcriptomics
In this interview, Dr George Emanuel discusses the power of spatial transcriptomic profiling and some of the biggest trends in the field.
Next-Generation Sequencing for SARS-CoV-2 Surveillance
To gain some insights into the role of NGS in global SARS-CoV-2 surveillance, we spoke to Michelle Fraser, general manager, NGS for PerkinElmer. Michelle also explains how labs working in this area can increase their throughput, decrease associated costs and simplify the analysis of NGS data collected.
Harnessing T Cells To Detect Disease
In this interview, Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies, discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases including SARS-CoV-2.
Lateral Flow Assay Development
Here we summarize the webinar that was hosted by Klaus Hochleitner, PhD., which provides an overview of the important factors and considerations for robust lateral flow assay development.
Detecting Residual Cancer Using Whole-Genome Sequencing and Artificial Intelligence
When a tumor is surgically removed, small amounts of residual cancer can remain at a level that is undetectable with current imaging or blood-based approaches. In this interview, Technology Networks spoke with Asaf Zviran, co-founder and CEO of C2i Genomics to find out more about the company’s C2-Intelligence Platform for the detection of trace amounts of cancer.
Ingestible Technologies for Diagnosis of Gastrointestinal Disorders
Progenity’s Christopher Wahl provides his insights into the research and work being done specifically with Progenity’s novel ingestible lab-in-a-capsule, PIL Dx.
How Can Informatics Make the Post-COVID Workplace Safe and Secure?
As COVID-19 vaccination programs kick into gear, private and public workplaces are weighing up the risks and benefits of asking employees to return to the office. Affinity Empowering Inc, who offer workplace eHealth compliance services, have rolled out an end-to-end COVID-19 testing program to assist employers in their return to work protocols. We spoke to Affinity CEO Scott Storrer to find out more.